Publications by authors named "S Grau"

Objectives: To describe the pharmacokinetics (PK) of linezolid in plasma and pleural fluid (PF) in critically ill patients with proven or suspected Gram-positive bacterial infections.

Patients And Methods: Observational PK study in 14 critically ill patients treated with linezolid at standard doses. Blood and PF samples were collected and analysed by HPLC.

View Article and Find Full Text PDF

Background: Following surgery, patients with newly diagnosed glioblastoma frequently enter clinical trials. Nuanced risk assessment is warranted to reduce imbalances between study arms. Here, we aimed (I) to analyze the interactive effects of residual tumor with clinical and molecular factors on outcome and (II) to define a postoperative risk assessment tool.

View Article and Find Full Text PDF

: Antimicrobial consumption (AMC) data in Latin America are scarce and usually spread out across different sources used to make AMC calculations, making it difficult to both standardize and compare regions through similar time frames. The main objective was to analyze AMC trends in Social Security tertiary care hospitals in Costa Rica in the period spanning January 2017 to December 2021, using both the defined daily dose (DDD)/100 bed days and DDD/100 discharges. : This is a retrospective observational study of antimicrobial consumption.

View Article and Find Full Text PDF

Background And Purpose: In recent years, there has been a growing interest in the study of resting neural networks in different neurological and mental disorders. While previous studies suggest that the default mode network (DMN) may be altered in dyscalculia, the study of resting-state networks in the development of numerical skills, especially in children with developmental dyscalculia (DD), is scarce and relatively recent. Based on this, this study examines differences in resting-state functional connectivity (rs-FC) data of children with DD using functional connectivity multivariate pattern analysis (fc-MVPA), a data-driven methodology that summarizes properties of the entire connectome.

View Article and Find Full Text PDF
Article Synopsis
  • Liposomal amphotericin B (L-AmB) is a key treatment for severe fungal infections, but it may pose risks for kidney damage in critically ill patients.
  • A study analyzed 67 patients treated with L-AmB for over 48 hours to determine the incidence of acute kidney injury (AKI), revealing that 26.8% of patients developed AKI, with lower rates in those at higher initial risk.
  • Key factors contributing to AKI included norepinephrine use, SOFA scores, and certain laboratory results, indicating that while L-AmB appears safe, AKI development is influenced by multiple factors.
View Article and Find Full Text PDF